Merck and Isomorphic Labs enter strategic research collaboration
FROM THE WIRE · FINANCE.YAHOO.COM
RAHWAY, N.J., November 19, 2026--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Isomorphic Labs, an AI-first drug design and development company, today announced a research collaboration that brings together Isomorphic Labs' AI…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishAn AI-driven oncology research deal that may strengthen Merck's pipeline without immediate revenue impact.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Merck and Isomorphic Labs will collaborate on discovering small molecule therapeutic candidates.
- 02Isomorphic Labs will perform in silico predictions and deliver molecular designs.
- 03Merck will handle preclinical and clinical development, manufacturing and commercialization.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets